{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:42:00Z","timestamp":1789558920407,"version":"build-2803163510"},"reference-count":23,"publisher":"Japanese Society of Veterinary Science","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1292\/jvms.12-0520","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T04:15:10Z","timestamp":1363320910000},"page":"1067-1070","source":"Crossref","is-referenced-by-count":22,"title":["<i>In Vitro<\/i> Susceptibility of <i>Mycoplasma hyopneumoniae<\/i> Field Isolates and Occurrence of Fluoroquinolone, Macrolides and Lincomycin Resistance"],"prefix":"10.1292","volume":"75","author":[{"given":"Pacharee","family":"THONGKAMKOON","sequence":"first","affiliation":[{"name":"National Institute of Animal Health, Bangkok 10900, Thailand"},{"name":"Department of Agriculture, Tokyo University of Agriculture, Tokyo 156\u20138502, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharachai","family":"NARONGSAK","sequence":"additional","affiliation":[{"name":"National Institute of Animal Health, Bangkok 10900, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"KOBAYASHI","sequence":"additional","affiliation":[{"name":"National Institute of Animal Health, Tsukuba, Ibaraki 305\u20130856, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornpen","family":"PATHANASOPHON","sequence":"additional","affiliation":[{"name":"National Institute of Animal Health, Bangkok 10900, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"KISHIMA","sequence":"additional","affiliation":[{"name":"Diseases Investigation Center, Subang, West Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"YAMAMOTO","sequence":"additional","affiliation":[{"name":"Department of Agriculture, Tokyo University of Agriculture, Tokyo 156\u20138502, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bousquet, E., Morvan, H., Aitken, I. and Morgan, J. H. 1997. Comparative in vitro<\/i> activity of doxycycline and oxytetracycline against porcine respiratory pathogens. Vet. Rec. 141: 37–40.","DOI":"10.1136\/vr.141.2.37"},{"key":"2","unstructured":"2. Clinical and Laboratory Standards Institute 2010. Performance standards for antimicrobial disk and dilution susceptibility test for bacteria isolated from animal, Approved standard, 3rd ed. M31-A3 Wayne, Pa."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Furneri, P. M., Rappazzo, G., Musumarra, M. P., Tempera, G. and Roccasalva, L. S. 2000. Genetic basis of natural resistance to erythromycin in Mycoplasma hominis<\/i>. J. Antimicrob. Chemother. 45: 547–548.","DOI":"10.1093\/jac\/45.4.547"},{"key":"4","unstructured":"4. Gautier-Bouchardon, A. V., Reinhardt, A. K., Kobisch, M. and Kempf, I. 2002. In vitro<\/i> development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae<\/i> and Mycoplasma synoviae<\/i>. Vet. Microbiol. 88: 47–58."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hannan, P. C. T. 2000. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. Vet. Res. 31: 373–395.","DOI":"10.1051\/vetres:2000100"},{"key":"6","unstructured":"6. Hannan, P. C. T., Windsor, H. M. and Ripley, P. H. 1997. In vitro <\/i>susceptibilities of recent field isolates of Mycoplasma hyopneumoniae<\/i> and Mycoplasma hyosynoviae<\/i> to valnemulin (Econor®), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae<\/i>. Res. Vet. Sci. 63: 157–160."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hannan, P. C. T., Windsor, G. D., de Jong, A., Schmeer, N. and Stegemann, M. 1997. Comparative susceptibilities of various animal-pathogenic mycoplasma to fluoroquinolones. Antimicrob. Agents Chemother. 41: 2037–2040.","DOI":"10.1128\/AAC.41.9.2037"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hooper, D. C. 1999. Mechanisms of flouroquinolones resistance. Drug Resist. Updat. 2: 38–55.","DOI":"10.1054\/drup.1998.0068"},{"key":"9","unstructured":"9. Kenny, G. E. and Cartwright, F. D. 1991. Susceptibility of Mycoplasma pneumoniae<\/i> to several new quinolones, tetracycline, and erythromycin. Antimicrob. Agents Chemother. 35: 587–589."},{"key":"10","unstructured":"10. Kobayashi, H., Kanazaki, M., Hata, E., Nishimoi, K. and Eguchi, M. 2008. Development of a rapid screening technique for the detection of macrolide-resistant strains of Mycoplasma hyopneumoniae<\/i> in swine. Bull. Natl. Inst. Anim. Health. 114: 1–7 (in Japanese)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Le Carrou, J., Laurentie, M., Kobisch, M. and Gautier-Bouchardon, A. V. 2006. Persistence of Mycoplasma hyopneumoniae<\/i> in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC<\/i> gene. Antimicrob. Agents Chemother. 50: 1959–1966.","DOI":"10.1128\/AAC.01527-05"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Maes, D., Segales, J., Meyns, T., Sibila, M., Pierters, M. and Haesebrouck, F. 2008. Control of Mycoplasma hyopneumoniae<\/i> infections in pigs. Vet. Microbiol. 126: 297–309.","DOI":"10.1016\/j.vetmic.2007.09.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mattsson, J. G., Bergstrom, K., Wallgren, P. and Johansson, K. E. 1995. Detection fo Mycoplasma hyopneumoniae<\/i> in nose swabs from pigs by in vitro amplification of the 16S rRNA gene. J. Clin. Microbiol. 33: 893–897.","DOI":"10.1128\/JCM.33.4.893-897.1995"},{"key":"14","unstructured":"14. Narongsak, W. and Thongkamkoon, P. 2002. In vitro Antimicrobial susceptibility test of Mycoplasma hyopneumoniae<\/i>. J. Thai Vet. Med. Assoc. 53: 35–44 (in Thai)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Prapasarakul, N., Tummaruk, P., Niyomtum, W., Tripipat, T. and Serichantalergs, O. 2010. Virulence genes and antimicrobial susceptibilities of hemolytic and nonhemolytic Escherichia coli<\/i> isolated from post-weaning piglets in central Thailand. J. Vet. Med. Sci. 72: 1603–1608.","DOI":"10.1292\/jvms.10-0124"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Senterfit, L. B. 1983. Antibiotic sensitivity testing of Mycoplasma. pp. 397–401. In<\/i>: Methods in Mycoplasmology (Razin, S. and Tully, J.G. eds.), Academic Press, New York.","DOI":"10.1016\/B978-0-12-583802-3.50054-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Stakenborg, T., Vicca, J., Butaye, P., Maes, D., Minion, F. C., Peeters, J., de Kruif, A. and Haesebroick, F. 2005. Characterization of in vivo<\/i> acquired resistant of Mycoplasma hyopneumoniae<\/i> to macrolides and lincosamides. Microb. Drug Resist. 11: 290–294.","DOI":"10.1089\/mdr.2005.11.290"},{"key":"18","unstructured":"18. Takahashi, K., Kuniyasu, C., Yoshida, Y. and Momotani, E. 1978. Sensitivity in vitro<\/i> to macrolide antibiotics and tetracyclines of Mycoplasma hyopneumoniae<\/i> isolated from pneumonic porcine lung. Nat. Inst. Anim. Hlth. Quart. 18: 41–42."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tanner, A. C., Erickson, B. Z. and Ross, R. F. 1993. Adaptation of the Sensititre® broth microdilution technique to antimicrobial susceptibility testing of Mycoplasma hyopneumoniae<\/i>. Vet. Microbiol. 36: 301–306.","DOI":"10.1016\/0378-1135(93)90096-P"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ter Laak, E. A., Pijpers, A., Noordergraaf, J. H., Schoevers, E. C. and Verheijden, J. H. 1991. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma<\/i> species to antimicrobial agents. Antimicrob. Agents Chemother. 35: 228–233.","DOI":"10.1128\/AAC.35.2.228"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vicca, J., Stakenborg, T., Maes, D., Butaye, P., Peetres, J., de Kruif, A. and Haesebrouck, F. 2004. In vitro susceptibilities of Mycoplasma hyopneumoniae<\/i> field isolates. Antimicrob. Agents Chemother. 48: 4470–4472.","DOI":"10.1128\/AAC.48.11.4470-4472.2004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Vicca, J., Maes, D., Stakenborg, T., Butaye, P., Minion, F., Peerters, J., de Kruif, A., Decostere, A. and Haesebrouck, F. 2007. Resistance mechanism against fluoroquinolones in Mycoplasma hyopneumoniae<\/i> field isolates. Microb. Drug Resist. 13: 166–170.","DOI":"10.1089\/mdr.2007.716"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yamamoto, K., Koshimizu, K. and Ogata, M. 1986. In vitro<\/i> susceptibility of Mycoplasma hyopneumoniae<\/i> to antibiotics. Jpn. J. Vet. Sci. 48: 1–5.","DOI":"10.1292\/jvms1939.48.1"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/75\/8\/75_12-0520\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T01:10:59Z","timestamp":1617066659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/75\/8\/75_12-0520\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.12-0520","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}